• Skip to primary navigation
  • Skip to content
  • Skip to footer
CardioCell

CardioCell

Breakthrough Cardiovascular Technology

  • About Us
    • Overview
    • Board of Directors
    • Scientific Advisory Board
  • Technology
    • Our Stem Cells
    • Manufacturing
    • Quality Control
    • Exclusive License
  • Clinical Trials
    • Overview
    • Chronic Heart Failure
    • Heart Failure in Patients With Left Ventricular Assist Devices
    • Acute Myocardial Infarction
  • News
    • Press Releases
    • Media Coverage
    • Publications
  • Events
  • LinkedIn

Press Releases

September 8, 2014

CardioCell Scientific Advisory Board Chair Debates in “Strategies for Cardiovascular Repair” Didactic Science Symposium at TCT2014

News Sep 8, 2014 CardioCell Scientific Advisory Board Chair Debates in “Strategies for Cardiovascular Repair” Didactic Science Symposium at TCT2014 WASHINGTON, D.C. – TCT2014 – Sept. 8, 2014 – CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic

Read More

Press Releases

July 8, 2014

CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy

News Jul 8, 2014 CardioCell Begins Phase IIa Clinical Trial Using itMSC Therapy to Treat Chronic Heart Failure (HF) Due to Non-Ischemic Cardiomyopathy SAN DIEGO — July 8, 2014 — CardioCell LLC, a Stemedica Cell Technologies Inc. subsidiary that creates allogeneic stem-cell therapies

Read More

Press Releases

June 16, 2014

CardioCell Scientific Advisory Board Member Presents at the 2014 Lugano Stem Cell Meeting

News Jun 16, 2014 CardioCell Scientific Advisory Board Member Presents at the 2014 Lugano Stem Cell Meeting LUGANO, SWITZERLAND – LUGANO STEM CELL MEETING – June 16, 2014 – CardioCell LLC, a Stemedica Cell Technologies subsidiary that creates allogeneic stem-cell therapies for

Read More

News,  Press Releases

May 27, 2014

Indonesia’s BPOM Grants IND Approval for SCI to Conduct a Phase II Clinical Trial Using Stemedica’s Mesenchymal Stem Cells to Treat Acute Myocardial Infarction

News May 27, 2014 Indonesia’s BPOM Grants IND Approval for SCI to Conduct a Phase II Clinical Trial Using Stemedica’s Mesenchymal Stem Cells to Treat Acute Myocardial Infarction SAN DIEGO — May 27, 2014 — Stemedica Cell Technologies Inc., a leading manufacturer of adult, allogeneic

Read More

News,  Press Releases

May 14, 2014

CardioCell Scientific Advisory Board Members Present at the 2014 World Congress on Acute Heart Failure

News May 14, 2014 CardioCell Scientific Advisory Board Members Present at the 2014 World Congress on Acute Heart Failure ATHENS, GREECE – WORLD CONGRESS ON ACUTE HEART FAILURE– May 14, 2014 – CardioCell announces presentations by prominent chronic heart failure (CHF) opinion leaders

Read More

Press Releases

April 21, 2014

CardioCell Scientific Advisory Board Chair Joins “Novel Technologies in Stem Cell Research” Panel at the 2014 Stem Cell Summit

News Apr 21, 2014 CardioCell Scientific Advisory Board Chair Joins “Novel Technologies in Stem Cell Research” Panel at the 2014 Stem Cell Summit CAMBRIDGE, MASS. – STEM CELL SUMMIT 2014 – April 21, 2014 – CardioCell announces a presentation by noted cardiologist Dr. Stephen Epstein,

Read More

Press Releases

April 2, 2014

FDA Grants IND Approval for Phase IIa Clinical Trial Using CardioCell’s itMSC Therapy to Treat Dilated Chronic Heart Failure

News Apr 2, 2014 FDA Grants IND Approval for Phase IIa Clinical Trial Using CardioCell’s itMSC Therapy to Treat Dilated Chronic Heart Failure SAN DIEGO — April 2, 2014 — CardioCell LLC has just received the FDA’s investigational new drug (IND) approval for a United States-based,

Read More

Press Releases

  • « Previous Page
  • Page 1
  • Page 2
  • Page 3
  • Page 4

Footer

About Us

  • Overview
  • Board of Directors
  • Scientific Advisory Board

Technology

  • Our Stem Cells
  • Manufacturing
  • Quality Control
  • Exclusive License

Clinical Trials

  • Overview
  • Chronic Heart Failure
  • Heart Failure in Patients With Left Ventricular Assist Devices
  • Acute Myocardial Infarction
<section id="bpfwp_contact_card_widget-1" class="widget widget_bpfwp_contact_card_widget"><div class="widget-wrap"><h3 class="widgettitle widget-title">Contact</h3>
info@stemcardiocell.com
</div></section>

Copyright © 2023 · Business Pro Theme on Genesis Framework · WordPress · Log in